Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05741723 · ClinicalTrials.gov registry record
OCS DCD Heart + CAP Continued Follow-Up
A clinical trial of Heart Transplant, sponsored by TransMedics.
- Active
- Registry status
- 276
- Enrollment target
- 20
- Study locations
NCT05741723 is a study of Heart Transplant that is active but no longer recruiting, run by TransMedics. The registered enrollment target is 276 participants, below the 8,507-participant average among 12 other Heart Transplant trials with a reported enrollment target (97% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT05741723, a study of Heart Transplant, is active but no longer recruiting, sponsored by TransMedics.
- ACTIVE NOT RECRUITING
- Registry status
- 276 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Conditions Studied
Interventions
- DEVICE OCS Heart
Study Locations (20)
California
- University of California San Diago - La Jolla
- Stanford University - Palo Alto
Florida
- Mayo Clinic Florida - Jacksonville
- AdventHealth Orlando - Orlando
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
Minnesota
- Minneapolis Heart Institute - Minneapolis
- University of Minnesota - Minneapolis
New York
- Nyph/Cumc - New York
- Montefiore - The Bronx
Wisconsin
- University of Wisconsin - Madison
- Froedtert & the Medical College of Wisconsin - Milwaukee
Connecticut
- Yale New Haven Hospital - New Haven
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05741723
The ClinicalTrials.gov registry entry for NCT05741723 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,507-participant average among 12 other Heart Transplant trials with a reported enrollment target (97% lower). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Heart is the first listed.
NCT05741723 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05741723 about?
NCT05741723 is a clinical study titled "OCS DCD Heart + CAP Continued Follow-Up". The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
What is the current status of trial NCT05741723?
This trial is currently active not recruiting. The enrollment target is 276 participants. The study started on 2019-11-26. Estimated completion is 2026-10.
What conditions does trial NCT05741723 study?
This clinical trial studies the following conditions: Heart Transplant.
What interventions are being tested in trial NCT05741723?
The interventions under investigation include: OCS Heart (DEVICE).
Who is sponsoring clinical trial NCT05741723?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05741723 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
US National OCS Heart Perfusion (OHP) Registry
RECRUITING
-
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
RECRUITING · NA
-
Belatacept in Heart Transplantation
RECRUITING · Phase 2
-
Enhancing Heart Allograft Function With the OCS Heart System Trial
RECRUITING · NA
-
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.